Fecha |
Titulo |
Autor |
1997 |
A national survey of the complications of endometrial destruction for menstrual disorders, the MISTLETOE study |
Overton et al |
2002 |
Techniques for endometrial ablation in the treatment of abnormal uterine bleeding |
Battista et al |
2002 |
A Randomized, Multicenter Trial of Safety and Efficacy of the NovaSure System in the Treatment of Menorrhagia |
Cooper et al |
2002 |
NovaSure Impedance-Controlled System for Endometrial Ablation |
Gallinat et al |
2003 |
A double-blind randomized trial comparing the Cavaterm™ and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding |
Abbott et al |
2003 |
Quality of Life Should Be Considered the Primary Outcome for measuring Success of Endometrial Ablation |
Abbott et al |
2003 |
Endometrial ablation with NovaSure Endometrial Ablation: A Pilot Study |
Busund et al |
2003 |
The NovaSure Endometrial Ablation Procedure: A 10-Year Review |
Gimpelson |
2003 |
A Look at Intra- and Post-Operative Pain Assessment with ThermaChoice™ versus NovaSure® Endometrial Ablation Systems |
Laberge et al |
2003 |
Assessment and Comparison of Intraoperative and Postoperative Pain Associated with NovaSure and ThermaChoice Endometrial Ablation Systems |
Laberge et al |
2004 |
Randomised controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation |
Bongers et al |
2004 |
Summary of Safety and Effectiveness Data from FDA: A Valuable Source of Information on the Performance of Endometrial Ablation Devices |
Cooper et al |
2004 |
NovaSure impedance controlled system for endometrial ablation: Three-year follow-up on 107 patients |
Gallinat et al |
2004 |
Clinical outcomes and costs with the Levonorgestrel-Releasing Intrauterine System or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up |
Hurskainen et al |
2004 |
Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection |
Rauramo et al |
2004 |
A randomized trial among women with heavy menstruation -- impact of a decision aid on treatment outcomes and costs |
Vuorma et al |
2005 |
NovaSure bipolar radiofrequency endometrial ablation: report of 200 cases |
Baskett et al |
2005 |
Bipolar radio frequency endometrial ablation compared with balloon endometrial ablation indysfunctional uterine bleeding: Impact on patients’health-related quality of life |
Bongers et al |
2005 |
Thermal Endometrial Ablation in Dysfunctional Uterine Bleeding: An Economic Comparison of Bipolar Ablation and Balloon Ablation |
Bongers et al |
2005 |
A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss |
Cooper et al |
2005 |
An Impedance-Controlled System for Endometrial Ablation Five Year Follow Up |
Gallinat et al |
2006 |
Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study |
Sabbah et al |
2006 |
Assessment of New Technology in the Treatment of Idiopathic Menorrhagia and uterine Leiomyomata |
Sharp et al |
2007 |
Global Endometrial Ablation for Menorrhagia in Women with Bleeding Disorders |
El-Nashar et al |
2007 |
NovaSure impedance controlled endometrial ablation: Long-term follow-up results |
Fulop et al |
2007 |
An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients |
Gallinat et al |
2007 |
Radiofrequency global endometrial ablation followed by hysteroscopic sterilization |
Hopkins et al |
2007 |
Long-term complications of endometrial ablation: Cause, diagnosis, treatment, and prevention |
Mccausland et al |
2008 |
Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation |
Kleijn et al |
2009 |
Feasibility of endometrial assessment after thermal ablation |
Ahonkollio et al |
2009 |
Intestinal Injuries Associated with the NovaSure Bipolar Device |
Baggish et al |
2009 |
Prediction of Treatment Outcomes After Global Endometrial Ablation |
El Nashar et al |
2009 |
Levonorgestrel-releasing Intrauterine System – The discontinuing story |
Ewies et al |
2009 |
Endometrial Ablation with Paracervical Block |
Penninx et al |
2010 |
Pathologic characteristics of hysterectomy specimens in women undergoing hysterectomy after GEA |
Carey et al |
2010 |
Combined Bipolar Radiofrequency Endometrial Ablation with Levonorgestrel Intrauterine System: A Novel Approach for Challenging Cases |
El-Nashar et al |
2010 |
Health-related quality of life and patient satisfaction after global endometrial ablation for menorrhagia in women with bleeding disorders: a follow-up survey and systematic review |
El-Nashar et al |
2010 |
Quality of Life Survey, Success Rate, and Descriptive Analysis after Novasure – Endometrial Ablation in a Community Setting |
Fakih et al |
2010 |
Quality Hysterosalpingography Following Concomitant Adiana Transcervical Sterilization and NovaSure Endometrial Ablation with Histopathology Correlation |
Garza-Leal et al |
2010 |
Comparison of Physician Rated Performance Characteristics and Ease-of-Use for a New RF Catheter Design |
Jamieson et al |
2010 |
Tranexamic Acid Treatment for Heavy Menstrual Bleeding |
Lukes et al |
2010 |
Evaluation of the Adiana Matrix during Concomitant NovaSure Endometrial Ablation |
Macbride et al |
2010 |
Retrospective Comparative Study between Impedance Radiofrequency Probe (Novasure) and Microwave Endometrial Ablation for the Treatment of Heavy Menstrual Period |
Meti et al |
2010 |
A Retrospective Review of Patient Outcomes Comparing Novasure, Thermablate, Microwave Endometrial Ablation (MEA) and the Mirena Intrauterine System (IUS) |
Okane et al |
2010 |
Bipolar Radiofrequency Endometrial Ablation Compared With Hydrothermablation for Dysfunctional Uterine Bleeding, A Randomized Controlled Trial |
Penninx et al |
2010 |
Clinical Experience with Next Generation NovaSure for Endometrial Ablation: A Prospective Study |
Pollock et al |
2010 |
Endometrial Ablation What Counts? |
Sharp et al |
2010 |
Novasure as a Mechanical Endometrial Preparation Agent Compared to GnRH Analogs Prior to Roller Ball Ablation |
Uppal et al |
2011 |
Endometrial Cancer After Endometrial Ablation: Systematic Review of Medical Literature |
Al Hilli et al |
2011 |
Endometrial ablation with the NovaSure system in Iran |
Asgari et al |
2011 |
The Effect of NovaSure Endometrial Ablation on Premenstrual Anxiety and Emotional Irritability |
Ashford et al |
2011 |
Pathologic Characteristics of Hysterectomy Specimens in Women Undergoing Hysterectomy after Global Endometrial Ablation |
Carey et al |
2011 |
Bipolar radiofrequency compared with thermal balloon endometrial ablation in the office: a randomized controlled trial |
Clark et al |
2011 |
Success rate, quality of life, and descriptive analysis after generalized endometrial ablation in an obese population |
Fakih et al |
2011 |
Randomized Trial of Medication Versus Radiofrequency Ablation in the Initial Management of Menorrhagia |
Famuyide et al |
2011 |
NovaSure endometrial ablation under local anaesthesia in an outpatient setting: An observational study |
Kalkat & Cartmill |
2011 |
Efficacy and safety of global endometrial ablation after cesarean delivery: a cohort study |
Khan et al |
2011 |
Improved Premenstrual Syndrome Symptoms after NovaSure Endometrial Ablation |
Lukes et al |
2011 |
Thermal Analysis of an Adiana® Procedure on a Concomitant and Subsequent NovaSure® Procedure |
Martin et al |
2011 |
Concomitant NovaSure Endometrial Ablation and Essure Tubal Sterilization – Review of 100 Cases |
Mircea et al |
2011 |
Five-Year Follow-Up After Comparing Bipolar Endometrial Ablation With Hydrothermablation for Menorrhagia |
Penninx et al |
2011 |
Online Survey of Women’s Awareness and Perception of Treatment Options for heavy Menstrual Bleeding |
Presthus et al |
2011 |
Global–local anaesthesia: combining paracervical block with intramyometrial prilocaine in the fundus significantly reduces patients' perception of pain during radio-frequency endometrial ablation (NovaSure procedure) in an office setting |
Skensved et al |
2012 |
Uterine Ultrasound Findings After Radiofrequency Endometrial Ablation Correlation With Symptoms |
Alhilli et al |
2012 |
Minimally Invasive Endometrial Ablation Device Complications and Use Outside of the Manufacturers' instructions |
Brown et al |
2012 |
Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis |
Daniels et al |
2012 |
Comparative Efficacy of NovaSure, the Levonorgestrel-releasing Intrauterine System, and Hysteroscopic Endometrial Resection in the Treatment of Menorrhagia: Randomized Clinical Trial |
Ghazizadeh et al |
2012 |
The Issue of Scarring Post-Ablation: The Data |
Lukes et al |
2012 |
Next-generation NovaSure® device for endometrial ablation: assessing ease-of-use among physicians |
Pollock et al |
2012 |
Novasure as a Mechanical Endometrial Preparation Agent in Large Uteri |
Potti et al |
2012 |
Hysterectomy Subsequent to Endometrial Ablation |
Shavell et al |
2012 |
Pregnancy Outcomes Following a NovaSure® Endometrial Ablation Procedure |
Smith et al |
2013 |
Radiofrequency Endometrial Ablation in Patients With a History of Low Transverse Cesarean Delivery |
Adkins et al |
2013 |
Nonresectoscopic Endometrial Ablation in High-Risk Surgical Patients: A Cohort Study |
Ajao et al |
2013 |
Rates of subsequent surgery following endometrial ablation among English women with menorrhagia: population-based cohort study |
Bansi-Matharu et al |
2013 |
The long-term outcomes of endometrial ablation in the treatment of heavy menstrual bleeding |
Daniels et al |
2013 |
Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding |
Fergusson et al |
2013 |
Endometrial ablation: comparative study between hysteroscopic resection and Novasure system |
Fresno-Alba et al |
2013 |
Levonorgestrel Intrauterine System versus medical therapy for menorrhagia |
Gupta et al |
2013 |
Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (NovaSure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial |
Herman et al |
2013 |
Ten-year follow-up of a randomised controlled trial comparing bipolar endometrial ablation with balloon ablation for heavy menstrual bleeding |
Herman et al |
2013 |
Endometrial Ablation: Is Tubal Ligation a Risk Factor for Hysterectomy |
Kreider et al |
2013 |
Endometrial resection and ablation techniques for heavy menstrual bleeding |
Lethaby et al |
2013 |
Does repeated endometrial destruction procedures decrease abnormal uterine bleeding and does it reduce the number of hysterectomy in this indication (french study) |
Levy-Zaubermann et al |
2013 |
Endometrial ablation for the treatment of heavy menstrual bleeding in obese women |
Madsen et al |
2013 |
Evaluation of endometrectomy by radiofrequency for premenopausal women |
Maillet et al |
2013 |
Curative Effects of Two New Endometrial Ablation Procedures Using Radiofrequency Thermocoagulation for the Treatment of Severe Abnormal Uterine Bleeding |
Yin et al |
2014 |
Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborative |
Corona et al |
2014 |
Endometrial Cancer After Endometrial Ablation vs Medical Management of Abdnormal Uterine Bleeding |
Dood et al |
2014 |
Comparative efficacy of NovaSure, the Levonorgestrel-releasing intrauterine system, and hysteroscopic endometrial resection in the treatment of menorrhagia: a randomized clinical trial |
Ghazizadeh et al |
2014 |
Ten-year literature review of global endometrial ablation with the NovaSure® device |
Gimpelson |
2014 |
Effect of undiagnosed deep adenomyosis after failed NovaSure endometrial ablation |
Mengerink et al |
2014 |
Subsequent Intervention Rates Following Thermablate and NovaSure Endometrial Ablations |
Powell et al |
2014 |
Preoperative uterine bleeding pattern and risk of endometrial ablation failure |
Smithling et al |
2014 |
Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland |
Soini et al |
2014 |
Evaluation of the NovaSure Endometrial Ablation Procedure in Women With Uterine Cavity Length Over 10cm |
Thiel et al |
2014 |
Ultrasound-Guided Reoperative Hysteroscopy for Managing Global Endometrial Ablation Failures |
Wortman et al |
2015 |
ACOG Practice Bulletin number 149: endometrial cancer |
ACOG |
2015 |
The effects of endometrial ablation on treatment planning in women with endometrial cancer |
Argall et al |
2015 |
Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial |
Athanatos et al |
2015 |
Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborative |
Corona et al |
2015 |
Endometrial Ablation: Normal Imaging Appearance and Delayed Complications |
Daub et al |
2015 |
Office-Based Gynecologic Surgical Procedures |
Emery et al |
2015 |
Radiofrequency endometrial ablation for the treatment of heavy menstrual bleeding among women at high surgical risk |
Fischer et al |
2015 |
Economic and clinical benefits of radiofrequency ablation versus hysterectomy in patients suffering from menorrhagia |
Kessel et al |
2015 |
Effect of undiagnosed deep adenomyosis after failed NovaSure endometrial ablation |
Mengerink et al |
2015 |
Combined Endometrial Ablation and Levonorgestrel Intrauterine System Use in Women With Dysmenorrhea and Heavy Menstrual Bleeding: Novel Approach for Challenging Cases |
Papadakis et al |
2015 |
Bipolar versus balloon endometrial ablation in the office: a randomized controlled trial |
Penninx et al |
2016 |
Effects of Endometrial Ablation on Treatment Planning in Women With Endometrial Cancer |
Argall et al |
2016 |
NovaSure Radiofrequency Ablation: 13 Years of Data, Experience, and Patient Outcomes |
Basinski et al |
2016 |
Economic and clinical benefits of endometrial radiofrequency ablation compared with other ablation techniques in women with menorrhagia: a retrospective analysis with german health claims data |
Bischoff-Everding et al |
2016 |
Local anaesthesia during endometrial ablation:a systematic review |
Bongers et al |
2016 |
NovaSure vs Oral Contraceptives: Medical therapy versus radiofrequency endometrial ablation in the initial treatment of heavy menstrual bleeding (iTOM Trial): A clinical and economic analysis |
Famuyide et al |
2016 |
Moving the NovaSure procedure into your office |
Hologic |
2016 |
Effectiveness of thermal balloon ablation versus NovaSure endometrial ablation in different age groups |
Hussain et al |
2016 |
Is endometrial ablation protective against endometrial cancer? A retrospective observational study |
Jones et al |
2016 |
Hysteroscopic local anesthetic intrauterine cornual block in office endometrial ablation: a randomized controlled trial |
Kumar et al |
2016 |
Efficacy and safety of endometrial ablation for treating abnormal uterine bleeding in pre- and postmenopausal women with liver cirrhosis |
Liu et al |
2016 |
Local anaesthesia during endometrial ablation: a systematic review |
Reinders et al |
2016 |
Intraoperative Predictors of Long-term Outcomes After Radiofrequency Endometrial Ablation |
Shazly et al |
2016 |
Therapeutic hysteroscopy in an outpatient office-based setting compared to conventional inpatient treatment: superior? a cohort study |
Smits et al |
2016 |
Levonorgestrel-releasing intrauterine system and the risk of breast cancer: A nationwide cohort study |
Soini et al |
2016 |
Outcomes and Postoperative Complications After Hysterectomies Performed for Benign Compared With Malignant Indications |
Wallace et al |
2016 |
Effect of Radiofrequency Endometrial Ablation on Dysmenorrhea |
Wyatt et al |
2017 |
Medical therapy versus radiofrequency endometrial ablation in the initial treatment of heavy menstrual bleeding (iTOM Trial): A clinical and economic analysis |
Famuyide et al |
2017 |
Medical therapy versus radiofrequency endometrial ablation in the initial treatment of heavy menstrual bleeding (iTOM Trial): A clinical and economic analysis |
Famuyide et al |
2017 |
NovaSure Endometrial Ablation: Real-World Experience and Clinical Data |
Hologic |
2017 |
Pregnancy after endometrial ablation |
Kohn et al |
2017 |
Severe complication following bipolar radiofrequency endometrial ablation immediately after placement of Essure micro-inserts: A case report |
Renou et al |
2017 |
Abnormal Uterine Bleeding Control by Sequential Application of Hysteroscopic Lesion Morcellation and Endometrial Ablation |
Rubino et al |
2017 |
Long-term Follow-up After Endometrial Ablation in Finland: Cancer Risks and Later Hysterectomies |
Soini et al |
2018 |
Utility of anesthetic block for endometrial ablation pain: a randomized controlled trial |
Klebanoff et al |
2018 |
Predictors of Long-Term NovaSure Endometrial Ablation Failure. |
Lybol et al |
2018 |
Evaluation of NovaSure global endometrial ablation in symptomatic adenomyosis :a longitudinal study with a 36 month follow-up |
Philip et al |
2018 |
Efficacy and patient satisfaction after NovaSure and Minerva® endometrial ablation for treating abnormal uterine bleeding: a retrospective comparative study |
Scordalakes et al |
2018 |
Women’s preferences for the Levonorgestrel Intrauterine System versus endometrial ablation for heavy menstrual bleeding |
van den Brink et al |
2018 |
Meta-analysis of bipolar radiofrequency endometrial ablation versus thermal balloon endometrial ablation for the treatment of HMB |
Zhai et al |
2019 |
The surgical treatment of idiopathic abnormal uterine bleeding: An analysis of 88,000 patients from the French exhaustive national hospital discharge database from 2009 to 2015 |
de Léotoing et al |
2019 |
Endometrial ablation; less is more? Historical cohort study comparing long-term outcomes from two time periods and two treatment modalities for 854 women |
Helleland et al |
2019 |
Endometrial resection and ablation techniques for heavy menstrual bleeding (Review) |
Rodriguez et al |
2019 |
Comparison of Combined Bipolar Radiofrequency Impedance-Controlled Endometrial Ablation with Levonorgestrel Intrauterine System versus Bipolar Radiofrequency Endometrial Ablation Alone in Women with Abnormal Uterine Bleeding |
Zhao et al |